About Contact Us Careers

Multiple Myeloma Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 2898
Published Date: Oct 10, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Multiple Myeloma Landscape

Bristol-Myers Squibb Company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Amgen Inc.
Johnson & Johnson
Novartis AG
Sanofi
Janssen Pharmaceuticals Inc.
Genentech, Inc.
AbbVie Inc.
Karyopharm

Browse Key Market Insights with Data Illustration:

Multiple Myeloma Market Size & Share, Growth Forecasts 2037

In the News

Abecma, a B-cell maturation antigen-directed CAR T cell immunotherapy, has been approved for the treatment of adult patients with relapsed or refractory (R/R) multiple myeloma, according to a statement from the pharmaceutical company Bristol-Myers Squibb.
The FDA has approved Johnson and Johnson's drug TECVAYLI, which is used to treat people with multiple myeloma that has relapsed or become resistant to treatment.

Author Credits: Radhika Pawar

Report ID: 2898
Published Date: Oct 10, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of multiple myeloma is assessed at USD 32.36 billion.

The multiple myeloma market size was over USD 28.89 billion in 2024 and is poised to reach USD 178.71 billion by the end of 2037, growing at around 14.8% CAGR during the forecast period i.e., between 2025-2037. Growing incidences of multiple myeloma, growing number of product unveilings and increase in the initiatives taken by the government will drive the market growth.

North America industry is holding the largest share of about 33% by 2037, owing to increasing demand for the treatment and implementation of advanced therapeutics in the region.

The major players in the market include Bristol-Myers Squibb Company, Amgen Inc., Johnson & Johnson, Novartis AG, Sanofi, Janssen Pharmaceuticals Inc., Genentech, Inc., AbbVie Inc., Karyopharm.

Inquiry Before Buying Request Free Sample